BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

BioNTech (BNTX) stock traded higher on Tuesday after Jefferies upgraded the COVID-19 vaccine maker to Buy, citing the ...

increased its price target on shares of BioNTech (NASDAQ:BNTX), listed on NASDAQ:BNTX, to $96 from the previous $90 while maintaining a Hold rating on the stock. The adjustment follows a recent ...

Today, Benzinga 's options scanner spotted 26 uncommon options trades for BioNTech. This isn't normal. The overall sentiment ...

On Friday, Jefferies, a financial services company, increased its price target on shares of BioNTech (NASDAQ:BNTX), listed on NASDAQ:BNTX, to $96 from the previous $90 while maintaining a Hold rating ...

BioNTech's shares have experienced a remarkable upswing, with the stock price soaring to $130.90 on NASDAQ, marking a 6.0% increase in the latest session. This surge represents a significant ...

JPMorgan upgraded BioNTech's stock from Underweight to Neutral, raising the price target from $91 to $125 based on promising data from the company's phase II and phase I/II trials for BNT327/PM8002.

On Tuesday, BioNTech SE (NASDAQ:BNTX) stock received an upgrade from a Jefferies analyst, who changed the rating from Hold to Buy and increased the price target to $150 from the previous $96. The ...